UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025... Show more
UnitedHealth Group (UNH) is a leading diversified healthcare enterprise serving millions through its two primary segments: UnitedHealthcare, which provides health insurance and benefits, and Optum, which offers health services, analytics, pharmacy care, and technology solutions. The company's business model focuses on value-based care, leveraging data analytics and integrated services to manage costs and improve outcomes. As the largest health insurer in the U.S. by market share, UNH holds a dominant position in the managed healthcare industry, competing with players like CVS Health (CVS) and Cigna (CI). Its strong fundamentals, including recurring revenue from premiums and scalable Optum operations, have underpinned recent stock resilience amid volatile medical loss ratios (MLR, the percentage of premiums spent on medical claims).
Over the last 30 days, UNH stock climbed +37%, moving from approximately $271 to $371 in a trend-driven rally with moderate volatility. The sharpest gains occurred post-Q1 earnings, pushing shares higher steadily.
In the past quarter, the stock advanced +30%, from around $286 to $371. Performance was range-bound early on with dips to $259 lows, followed by a steady recovery and acceleration into April, reflecting improving sentiment.
The primary catalyst was UnitedHealth Group's Q1 2026 earnings release on April 21, where adjusted earnings per share (EPS) hit $7.23, surpassing consensus estimates of $6.57, while revenues reached $111.7 billion against expectations of $109.6 billion. Shares surged over 7% the next day, extending gains as the company raised its full-year adjusted EPS outlook to more than $18.25. Easing medical costs in Medicare Advantage (MA) plans and favorable pricing assumptions for 2026 fueled optimism. Analyst sentiment shifted positively, with upgrades highlighting AI-driven efficiencies in Optum. Sector tailwinds, including healthcare demand amid economic stability, amplified the upward price movement.
The quarter's +30% gain stemmed from a broader turnaround narrative, overcoming early pressures from elevated MLR and utilization trends that drove shares to March lows near $259. Sustained recovery built on anticipated MA rate increases and cost discipline, culminating in the Q1 beat. Macro factors like stable interest rates supported insurer valuations, while institutional buying reflected confidence in UNH's scale. Competitive positioning strengthened via Optum's growth in value-based care, outpacing peers. Cumulative impacts from guidance hikes and earnings momentum outweighed prior headwinds, driving steady accumulation.
Tickeron’s Trending AI Robots page showcases the platform's top-performing AI-driven trading bots from a library of hundreds that analyze and trade thousands of tickers across various markets. These curated bots stand out based on recent performance metrics, win rates, and relevance to current market trends, employing diverse strategies such as trend-following, mean reversion, or momentum plays over short-term, swing, or long-term timeframes. Users can explore detailed stats like average returns, drawdowns, and Sharpe ratios to identify bots suited to their risk tolerance and portfolio needs. Whether for stock analysis or automated execution, this section highlights actionable tools powered by advanced pattern recognition and machine learning. Check out Trending AI Robots today to enhance your trading edge.
Investors should monitor upcoming Q2 earnings for updates on MLR trends and Optum growth. Medicare Advantage final rate notices and regulatory changes could influence margins. Macro factors like inflation, interest rates, and healthcare policy shifts remain key. Strategic developments in AI cost savings and potential M&A (mergers and acquisitions) in health services warrant attention. Risks include utilization spikes or competitive pressures, alongside catalysts from membership growth and guidance refinements.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The 50-day moving average for UNH moved above the 200-day moving average on May 14, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UNH advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 228 cases where UNH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for UNH moved out of overbought territory on May 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on May 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UNH as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for UNH turned negative on May 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
UNH broke above its upper Bollinger Band on May 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.498) is normal, around the industry mean (3.872). P/E Ratio (28.389) is within average values for comparable stocks, (39.073). Projected Growth (PEG Ratio) (1.306) is also within normal values, averaging (1.218). Dividend Yield (0.023) settles around the average of (0.021) among similar stocks. P/S Ratio (0.762) is also within normal values, averaging (0.553).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. UNH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of hospital and medical service plans
Industry ManagedHealthCare